Search for: "R. J. F."
Results 6441 - 6460
of 6,940
Sorted by Relevance
|
Sort by Date
7 Dec 2015, 3:33 am
“Capital punishment for the corporation. [read post]
30 May 2016, 9:02 pm
” The text said Adams wanted to make it clear to Edwards that “[y]ou are NOT welcome any longer at Wall Street Chiropractic, DO NOT ever step foot in there again, and stay the [F. . .] away from my husband and family!!!!!! [read post]
25 Jun 2021, 3:34 pm
See 938 F. 3d, at 620–621 (opinion of Costa, J.). [read post]
5 Aug 2014, 10:00 am
John Podesta, an insurance coverage attorney in San Francisco, brings us his perspective on why the Form Interrogatories for Construction Defect should be used. [read post]
15 Oct 2012, 3:45 am
With respect to the appraisal proceeding, they argued that ANRE’s failure to commence its appraisal proceeding within the 30-day period following the expiration of Capsag’s 20-day period to file such a proceeding, required dismissal under BCL §623(h)(2) which provides that “[i]f such proceeding is not instituted within such thirty day period, all dissenter’s rights shall be lost unless the supreme court, for good cause shown, shall otherwise… [read post]
20 May 2008, 10:02 am
Christopher J. [read post]
19 Mar 2007, 7:51 am
Burr, 25 F. [read post]
24 Jan 2010, 9:40 am
Your promotion and introduction into interstate commerce of the BioFind III (or Biofind), BioPack II (or BioPack), Light Patch, Spinal Pad, and the Knee Saver for these uncleared indications render them adulterated under section 501 (f)(1)(B) of the Act, for failure to obtain FDA premarket approval, and misbranded under section 502(o) of the Act, for failure to notify the agency of your intent to introduce the device into commercial distribution, as required by section… [read post]
9 Jul 2011, 9:48 am
., 435 U.S. 389, 410 (1978) (Brennan, J.)). [read post]
29 May 2020, 4:06 pm
" (Breyer, J., dissenting)).} [read post]
14 Feb 2010, 12:13 pm
A review of our records also revealed that your firm has not listed its product as required by section 510(j) of the Act. [read post]
12 May 2009, 12:20 pm
The new chief of the Antitrust Division, Christine Varney, today published an advance text of a speech she gave yesterday at the Center for American Progress. [read post]
24 Jun 2011, 1:24 pm
., 603 F.3d 571, 612 (9th Cir. 2010) (en banc)). [read post]
24 Feb 2021, 2:55 am
The TCJA raised corporate taxes through a limitation on the deductibility of net interest expense (scheduled to increase at the end of this year from 30 percent of earnings before interest, taxes, depreciation, and amortization to 30 percent of earnings before interest and taxes) and by requiring amortization of R&D expense beginning next year. [read post]
22 Jun 2010, 1:46 pm
*498 HAROLD R. [read post]
17 Oct 2021, 2:17 pm
R. [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
31 Dec 2016, 12:36 pm
, Tax Manager @KPMG_US // Views expressed are mine; tweets ≠ tax advice. (35) @rileytaxtweets – Peter J. [read post]
1 Feb 2008, 12:00 am
, (Intellectual Property Watch), (Out-Law), (Electronic Frontier Foundation), The UK High Court allows computer program patent claims in Astron Clinica & Ors v The Comptroller: (IPKat), (BLOG@IP::JUR), (Filemot), (IAM), (The IP Factor), (IP Updates), (IMPACT), (IPcentral Weblog), (Out-Law), (IPBiz),Tarceva (Erlotinib) - Roche patent infringement action against CIPLA before Delhi High Court: Many posts at: (Spicy IP) and… [read post]
5 Jan 2022, 7:16 am
Pix Credit: Michael A. [read post]
